Abstract: The invention herein relates to a pharmaceutical composition containing loratadine and derivatives thereof which is suitable for use in soft capsule dosage forms. A pharmaceutical composition according to the invention comprises loratadine and derivatives thereof in a pharmaceutically effective amount; and a solvent system comprising a mixture of medium chain fatty acids. The loratadine compositions exhibit good solubility and storage stability while maintaining bioavailability of the drug. The compositions also permit high concentrations of solubilized loratadine per total fill volume and thereby permit the use of smaller capsules to deliver the same dosage of drug.

Abstract: Systems and methods of providing mobile network management of assets on a network are presented. In accordance with the method, a network management server is provided to control a network asset on a network. The network asset is connected to the network management server via a connection path. A secure communication path is established between the network management server and a mobile wireless capable device. The network asset is managed via the secure communication path with the mobile wireless capable device. The network is administered via the secure communication path with the mobile wireless capable device.

Abstract: A fuel injection arrangement for internal combustion engines, particularly for diesel engines, is indicated, in which the fuel injection is divided into an advance injection and a main injection for the purpose of noise reduction. An advance injection unit (27) is provided for the purpose of proportioning the advance injection quantity and a fuel injection pump of a conventional construction is provided for proportioning the main injection quantity. For an optimal design of the advance injection quantity with respect to noise reduction without influencing the main injection quantity, the advance injection unit (27) comprises a high-pressure storage (28), which is compressed to injection pressure, and at least one solenoid valve (30), which is controlled with respect to time. The advance and main injections are preferably effected via separate nozzle cross sections (21, 22).